Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H22O9 |
Molecular Weight | 418.394 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@@H](OC2=CC=C(\C=C\C(=O)C3=C(O)C=C(O)C=C3)C=C2)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=YNWXJFQOCHMPCK-LXGDFETPSA-N
InChI=1S/C21H22O9/c22-10-17-18(26)19(27)20(28)21(30-17)29-13-5-1-11(2-6-13)3-8-15(24)14-7-4-12(23)9-16(14)25/h1-9,17-23,25-28H,10H2/b8-3+/t17-,18-,19+,20-,21-/m1/s1
Molecular Formula | C21H22O9 |
Molecular Weight | 418.394 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Isoliquiritin is a flavonoid glycoside compound from licorice possessing a broad spectrum of pharmacological activities including antioxidant, anti-inflammatory, and anti-depression activities. It was shown that isoliquiritin has a cytoprotective effect on corticosterone-induced neurotoxicity in PC12 cells, which may be related to its antioxidant action, inhibition of [Ca2+]i overload, and inhibition of the mitochondrial apoptotic pathway. In addition, it was found that isoliquiritin inhibited the p53-dependent pathway and showed crosstalk between Akt activities. Thus isoliquiritin may be an alternative agent for the treatment of lung cancer.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: map04115 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24247527 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18289754
in mice: isoliquiritin at doses of 10, 20 and 40 mg/kg significantly reduced the immobility time in the FST and TST in mice 30 min after treatment
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8593441
Isoliquiritin exhibited significant antifungal activity against the tested pathogens, especially, P. litchi Chen, with a minimum inhibitory concentration of 27.33 mg/L. The morphology of P. litchi Chen was apparently changed by isoliquiritin through cytoplasm leakage and distortion of mycelia.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:19:21 GMT 2023
by
admin
on
Sat Dec 16 08:19:21 GMT 2023
|
Record UNII |
2Y348H1V4W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5318591
Created by
admin on Sat Dec 16 08:19:21 GMT 2023 , Edited by admin on Sat Dec 16 08:19:21 GMT 2023
|
PRIMARY | |||
|
5041-81-6
Created by
admin on Sat Dec 16 08:19:21 GMT 2023 , Edited by admin on Sat Dec 16 08:19:21 GMT 2023
|
PRIMARY | |||
|
DTXSID901317746
Created by
admin on Sat Dec 16 08:19:21 GMT 2023 , Edited by admin on Sat Dec 16 08:19:21 GMT 2023
|
PRIMARY | |||
|
2Y348H1V4W
Created by
admin on Sat Dec 16 08:19:21 GMT 2023 , Edited by admin on Sat Dec 16 08:19:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |